Suppr超能文献

人参的化学成分、其生物转化产物及其作为高血压治疗药物的潜力。

Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension.

机构信息

University of Western Ontario, London, ON, N6G 2X6, Canada.

出版信息

Mol Cell Biochem. 2021 Jan;476(1):333-347. doi: 10.1007/s11010-020-03910-8. Epub 2020 Sep 17.

Abstract

Ginseng is an ancient perennial herb belonging to the family Araliaceae and genus Panax which has been used for medical therapeutics for thousands of years, particularly in China and other Asian cultures although increasing interest in ginseng has recently emerged in western societies. Ginseng is a complex substance containing dozens of bioactive and potentially effective therapeutic compounds. Among the most studied are the ginsenosides, which are triterpene saponins possessing a wide array of potential therapeutic effects for many conditions. The quantity and type of ginsenoside vary greatly depending on ginseng species and their relative quantity in a given ginseng species is greatly affected by extraction processes as well as by subjecting ginseng to various procedures such as heating. Adding to the complexity of ginsenosides is their ability to undergo biotransformation to bioactive metabolites such as compound K by enteric bacteria following ingestion. Many ginsenosides exert vasodilatating effects making them potential candidates for the treatment of hypertension. Their vascular effects are likely dependent on eNOS activation resulting in the increased production of NO. One proposed end-mechanism involves the activation of calcium-activated potassium channels in vascular smooth cells resulting in reduced calcium influx and a vasodilatating effect, although other mechanisms have been proposed as discussed in this review.

摘要

人参是一种古老的多年生草本植物,属于五加科人参属,几千年来一直被用于医疗治疗,特别是在中国和其他亚洲文化中,尽管最近西方社会对人参的兴趣也在增加。人参是一种复杂的物质,含有数十种具有生物活性和潜在疗效的治疗化合物。研究最多的是人参皂苷,它是三萜皂苷,对许多疾病具有广泛的潜在治疗作用。人参皂苷的数量和类型因人参种类而异,而在给定的人参种类中,其相对含量受提取过程以及对人参进行加热等各种处理的影响很大。人参皂苷的复杂性还在于它们在摄入后能够被肠道细菌转化为生物活性代谢物,如化合物 K。许多人参皂苷具有血管扩张作用,使它们成为治疗高血压的潜在候选药物。它们的血管作用可能依赖于内皮型一氧化氮合酶的激活,从而增加一氧化氮的产生。一种提出的终末机制涉及血管平滑肌细胞中钙激活钾通道的激活,导致钙内流减少和血管扩张作用,尽管正如本文所讨论的那样,已经提出了其他机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验